Drug Import 180-Day Admissibility Review Would “Eat Into” Shelf Life – CHPA
This article was originally published in The Tan Sheet
Executive Summary
A proposal to allow FDA 180 days to determine the admissibility of imported drugs, cosmetics and foods "would effectively place products in limbo for up to seven months," the Consumer Healthcare Products Association says in recent comments to the U.S. Customs Service
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning